GMOmics: Omics techniques as useful tools for adressing emerging gaps in GMO risk assessment

10/2017 – 07/2021

The concept of substantial equivalence has long being used in safety testing of GMO crops, but the term and the concept has no clear definition. Currently, the common practice has been the investigation of compositional and nutritional substances in the GMO. However, unintended changes in the GMO might not be identified by the analysis of such small number of components. It is an evolving view among regulators that omics techniques, such as proteomics and metabolomics, can be used to complement analytical tools to existing safety assessment procedures. Therefore, this project is about the application of omics technologies to investigate potential unintended metabolic alterations in genetically modified plants and for elaboration of their relevance for GMO risk assessment. In particular, metabolic disturbances will be investigated when different transgenic inserts are combined in a single plant (stacking), and when these plants are exposed to abiotic stressors, such as herbicide application and drought. The project is divided into three working packages each containing experiments to address specific research questions.

Principal Investigator: Sarah Zanon Agapito-Tenfen

Partners: Federal University of Santa Catarina/Brazil & GenØk Centre for Biosafety/Norway

GMOmics Project (UFOPLAN 2017 – FKZ: 3517841000) was funded by The German Federal Agency for Nature
Conservation (Bundesamt für Naturschutz, BfN) – 500,000 € award over four years

Contact | Kontakt

Scientific enquiries –

Administrative and press enquiries –